Lung cancer tumor marker analysis: A clinical laboratory perspective.

 Clinical laboratories are responsible for performing lung cancer tumor marker testing as part of routine clinical care. It is their responsibility to guarantee that the reported tumor marker results are reliable and meet the necessary quality standards for proper clinical use. During the different laboratory phases, pre-analytical, analytical and post-analytical, specific steps and processes can introduce errors and generate incorrect clinical interpretation. This editorial briefly outlines critical laboratory issues related to lung cancer tumor markers, specific for each of these three laboratory phases.

Citation

Huub H van Rossum, Stefan Holdenrieder. Lung cancer tumor marker analysis: A clinical laboratory perspective. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2024;46(s1):S9-S14

Mesh Tags

Substances

PMID: 38517828

search → result